Quantitative Approaches to Advancing Endpoint Development – With a Specific Focus on Cognition

Time: 12:00 pm
day: Day Two


• How best to identify endpoint targets for clinical trials from a quantitative perspective and optimize biomarkers & endpoints through digital technologies, imaging and patient reported outcomes to develop aggregated targets showing how different endpoints can co-vary
• The potential for the approach to identify aggregated outcomes in the psychiatry be used in other disease areas and be transdiagnostic
• Optimizing the translatable value of pre-clinical disease models to move towards human studies